Filing Details
- Accession Number:
- 0001140361-10-050671
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-21 13:46:37
- Reporting Period:
- 2010-12-17
- Filing Date:
- 2010-12-21
- Accepted Time:
- 2010-12-21 13:46:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1124105 | Targacept Inc | TRGT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1296025 | C Geoffrey Dunbar | C/O Targacept, Inc. 200 East First Street, Suite 300 Winston-Salem NC 27101 | Svp, Clin. Dev. & Reg. Affairs | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-17 | 2,100 | $1.75 | 3,253 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-17 | 2,100 | $26.08 | 1,153 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2010-12-20 | 8,882 | $1.75 | 10,035 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-12-20 | 8,882 | $26.02 | 1,153 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-12-17 | 2,100 | $0.00 | 2,100 | $1.75 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-12-20 | 2,100 | $0.00 | 2,100 | $1.75 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2010-12-20 | 6,782 | $0.00 | 6,782 | $1.75 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 2,100 | 2013-01-30 | No | 4 | M | Direct | |
| 0 | 2013-01-30 | No | 4 | M | Direct | |
| 0 | 2013-10-30 | No | 4 | M | Direct |
Footnotes
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.22, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.17, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This option vested in installments and became vested and exercisable in full upon completion of the issuer's initial public offering.
- Does not include 10,749 shares subject to the unexercised portion of this option for which the exercise price is $5.10 per share.
- This option vested in installments and became vested and exercisable in full on September 30, 2007.
- Does not include 29,638 shares subject to the unexercised portion of this option for which the exercise price is $5.10 per share.
Billionaire Hedge Funds
